ARTICLE | Clinical News
Alpha 1 Biomedicals regulatory update
July 6, 1993 7:00 AM UTC
Alpha 1 Biomedicals Inc. (ALBM) Alpha 1 Biomedicals Inc. (ALBM) said Thymosin alpha 1 received marketing approval in Italy as an adjuvant for influenza vaccine in patients undergoing renal dialysis....